Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease

KG Tolman, V Fonseca, A Dalpiaz, MH Tan - Diabetes care, 2007 - Am Diabetes Assoc
KG Tolman, V Fonseca, A Dalpiaz, MH Tan
Diabetes care, 2007Am Diabetes Assoc
METHODS—A Medline search without limitations of date (as of October 2005), language, or
humans was carried out by the authors. The following medical subject headings were
used:“Diabetes Mellitus, type 2”;“Fatty Liver”;“Hepatitis, Toxic”;“Sulfonylurea Compounds”;“
Thiazolidinediones”;“Rosiglitazone”;“Pioglitazone”;“Troglitazone”;“Hydroxymethylglutaryl-
CoA Reductase Inhibitors”;“Metformin”;“Acarbose”; and “Gemfibrozil” and free-text
terms:“fatty liver”,“steatohepatitis”,“nonalcoholic steatohepatitis”,“nonalcoholic fatty liver …
METHODS—
A Medline search without limitations of date (as of October 2005), language, or humans was carried out by the authors. The following medical subject headings were used:“Diabetes Mellitus, type 2”;“Fatty Liver”;“Hepatitis, Toxic”;“Sulfonylurea Compounds”;“Thiazolidinediones”;“Rosiglitazone”;“Pioglitazone”;“Troglitazone”;“Hydroxymethylglutaryl-CoA Reductase Inhibitors”;“Metformin”;“Acarbose”; and “Gemfibrozil” and free-text terms:“fatty liver”,“steatohepatitis”,“nonalcoholic steatohepatitis”,“nonalcoholic fatty liver disease”,“drug-induced hepatitis”, each drug name and “hepat*”, and each drug name. When full-text articles were not available in the English language, abstracts were included in the search. Abstracts from national meetings through October 2006 were included. The Food and Drug Administration (FDA) Web site was searched for hepatotoxicity reports using the free-text terms listed above.
Am Diabetes Assoc